The use of genes for performance enhancement: doping or therapy?

The use of genes for performance enhancement: doping or therapy?

Show other versions (1)

Recent biotechnological advances have permitted the manipulation of genetic sequences to treat several diseases in a process called gene therapy. However, the advance of gene therapy has opened the door to the possibility of using genetic manipulation (GM) to enhance athletic performance. In such ‘g...

Full description

Bibliographic Details
Main Authors:	R.S. Oliveira, T.F. Collares, K.R. Smith, T.V. Collares, F.K. Seixas
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2011-12-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Genetic manipulation Erythropoietin Vascular endothelial growth factor Insulin-like growth factor-1 Myostatin Bioethics
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2011001200001&lng=en&tlng=en

Similar Items

The use of genes for performance enhancement: doping or therapy?
by: R.S. Oliveira, et al.
Published: (2011-12-01)

Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study
by: Kenta Moriwaki, et al.
Published: (2019-06-01)

Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer
by: R I Knyazev, et al.
Published: (2015-09-01)

Effects of EPO Gene on Growth and Apoptosis of Lung Adenocarcinoma Cell Line A549
by: Jianqing WU, et al.
Published: (2009-09-01)

Neopterin as a Stimulator of Vascular Endothelial Growth Factor and Erythropoietin Gene Expression in an Ovarian Carcinoma Cell Line
by: Rieder Josef, et al.
Published: (2005-11-01)

Comparative analysis of serum and tumor vascular endothelial growth factor, insulin-like growth factor 1, matrix metalloproteinase 7 levels in patients with ovarian cancer
by: Ya. Z. Plieva, et al.
Published: (2018-01-01)

Growth Hormone and Neuronal Hemoglobin in the Brain—Roles in Neuroprotection and Neurodegenerative Diseases
by: Marion Walser, et al.
Published: (2021-01-01)

REGULATION OF BONE MARROW ANGIOGENESIS BY OSTEOBLASTS DURING BONE DEVELOPMENT AND HOMEOSTASIS
by: Ernestina eSchipani, et al.
Published: (2013-07-01)

Profiling of metabolic biomarkers in the serum of prostate cancer patients
by: F. Ali, et al.
Published: (2020-02-01)

Correlation of EPO and VEGF levels in serum and aqueous humor with ocular hemodynamics and oxidative stress - mitochondrial function in patients with glaucoma
by: Zhi-Ya Liu
Published: (2017-08-01)

Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats
by: Lu Jing, et al.
Published: (2012-09-01)

Bumetanide Suppression of Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy
by: Sibel Guzel, et al.
Published: (2020-02-01)

Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis
by: Ahmadou M. Jingi, et al.
Published: (2017-10-01)

IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
by: John B. Allard, et al.
Published: (2018-04-01)

Insulin-like growth factors: Ligands, binding proteins, and receptors
by: Derek LeRoith, et al.
Published: (2021-10-01)

Changes in Serum Levels of Growth Factors in Chronic Gastritis
by: L. V. Matveeva, et al.
Published: (2019-12-01)

Oxygen-Induced Retinopathy from Recurrent Intermittent Hypoxia Is Not Dependent on Resolution with Room Air or Oxygen, in Neonatal Rats
by: Kay D. Beharry, et al.
Published: (2018-05-01)

Peripheral Hormone Interactions with the Growth Hormone-Insulin-Like Growth Factor (GH-IGF) System in Rainbow Trout
by: Dickey, Lindsey Ann
Published: (2019)

Mechanisms of genetic regulation of IGF1 expression.
Published: (2012)

Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor
by: Chen-Yuan Gong, et al.
Published: (2013-10-01)

The Effect of Eight Weeks Resistance Training With and Without Vascular Occlusion on Physical Fitness Indexes, Growth Hormone, and Insulin-like Growth Factor in Male Judokas
by: Kazem Sabri, et al.
Published: (2017-10-01)

Cloning and expression of full-length human insulin-like growth factor binding protein 3 (IGFBP3) in the Escherichia coli
by: Emad Khodadadi, et al.
Published: (2015-01-01)

Angiogenesis-related factors in various clinical stages of hepatitis B-related hepatocellular carcinoma
by: HAN Zhen
Published: (2015-06-01)

Anti-VEGF therapy in retinopathy of prematurity
by: Qin Peng, et al.
Published: (2020-11-01)

The immunohistochemical landscape of the VEGF family and its receptors in glioblastomas
by: Luiz Victor Maia Loureiro, et al.
Published: (2020-03-01)

Role of microRNAs in skeletal muscle hypertrophy
by: Keisuke eHitachi, et al.
Published: (2014-01-01)

Detection of angiogenic factors in midtrimester amniotic fluid and the prediction of preterm birth
by: Sung Eui Lee, et al.
Published: (2016-08-01)

Plasma Levels of Myonectin But Not Myostatin or Fibroblast-Derived Growth Factor 21 Are Associated with Insulin Resistance in Adult Humans without Diabetes Mellitus
by: Freddy J. K. Toloza, et al.
Published: (2018-01-01)

ARTERIAL HYPERTENSION DURING THERAPY OF ONCOLOGICAL DISEASES WITH ANGIOGENESIS INHIBITORS: SERIOUS IMPEDIMENT OR CONTROLLED REACTION?
by: Zh. D. Kobalava, et al.
Published: (2017-06-01)

Do insulin-like growth factor associated proteins qualify as a tumor marker? results of a prospective study in 163 cancer patients*
by: Matuschek G, et al.
Published: (2011-10-01)

Investigation of insulin-like growth factors/insulin-like growth factor binding proteins regulation in metabolic syndrome patients
by: Somayeh Pouriamehr, et al.
Published: (2019-10-01)

The Role of Insulin-like Growth Factor-I and IGF-binding Proteins in Mammary Gland Development
by: Weber, Miriam S.
Published: (2014)

Effects of Shuangdan Mingmu capsule on the expressions of VEGF in the retina of diabetic rat models
by: Jun Peng, et al.
Published: (2018-11-01)

Estudio inmunocitoquímico y molecular de cultivo primario de tejido molar
by: Yinth Andrea Bernal, et al.
Published: (2006-12-01)

Blood Flow Restriction During Futsal Training Increases Muscle Activation and Strength
by: Sadegh Amani-Shalamzari, et al.
Published: (2019-05-01)

Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls
by: Hua-Pin Chang, et al.
Published: (2018-09-01)

Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients
by: Roberto Ria, et al.
Published: (2020-06-01)

Rice as bioreactor to produce functional human insulin-like growth factor-1 (1GF-1) and insulin-like growth factor binding protein-3 (1GFBP-3).
Published: (2007)

Prematür retinopatisinin tanısı ve lazer tedavisine cevabın takibinde VEGF ve IGF-1’in değeri
by: Cüneyt TAYMAN, et al.
Published: (2019-09-01)

Reduced Expression of Erythropoietin After Intravitreal Ranibizumab in Proliferative Diabetic Retinopathy Patients—Retrospective Interventional Study
by: Li Chen, et al.
Published: (2021-09-01)